Looking ahead, Morgan Stanley expects PB Fintech's stock to de-rate as core new business performance moderates in FY26.

Palantir (NASDAQ:PLTR) was given an Underweight rating at Morgan Stanley on Monday, as the firm sees a negative risk-reward ...

Underweight stock signals it may underperform, not necessarily a sell directive. Rebalance your portfolio if you own an underweight stock per its comparison group. Adjust investments based on ...

Morgan Stanley assumed coverage of Palantir (PLTR) with an Underweight rating and $60 price target Palantir’s commercial traction and ...